Mental Wellness

Mental Wellness in Grand Island, Nebraska offers Spravato (esketamine), an FDA-approved nasal spray for individuals struggling with depression and suicidal ideation who have not found relief with traditional treatments. Spravato works by targeting the N-methyl-D-aspartate (NMDA) receptor, providing a new approach to alleviating depressive symptoms.

Clinical studies have shown its effectiveness in reducing treatment-resistant depression and suicidal thoughts, offering hope for lasting mental wellness. The practice is dedicated to providing this cutting-edge treatment to patients seeking stability and healing.

Most insurance plans cover Spravato, and the team is committed to helping patients receive the care they need, working with both individuals and referring healthcare providers to explore this innovative depression treatment as a path forward.